A Product and Pipeline Analysis of the U.S. Type 2 Diabetes Mellitus Market

 


This research service presents a marketed and pipeline analysis of the U.S. type 2 diabetes mellitus market. According to the 2011 National Diabetes Fact Sheet, 25.8 million children and adults (or 8.3 percent of the population) in the United States suffer from diabetes. Type 2 diabetes mellitus is the most common form of diabetes; approximately 90 to 95 percent of diabetes patients suffer from type 2 diabetes mellitus. The purpose of this study is to highlight the current market landscape, and provide a competitive analysis of all marketed and pipeline drugs in development for type 2 diabetes mellitus. Dashboard slides are provided for all marketed and Phase 3 drugs in development for type 2 diabetes mellitus.

Regular Price: USD 1,500

Special Price USD 1,125

25% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,125

PAY BY INVOICE

Be the first to review this product

Table of Contents

A Product and Pipeline Analysis of the U.S. Type 2 Diabetes Mellitus MarketAnalysis of the U.S. Type 2 Diabetes Mellitus MarketResearch Service




Related Research

Release Date : 08-Aug-17

Region : North America

Release Date : 31-Jul-17

Region : North America

Release Date : 27-Jul-17

Region : North America

Release Date : 27-Jul-17

Region : North America

Release Date : 24-Jul-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.